e-learning
resources
Vienna 2009
Tuesday, 15.09.2009
Hot topics in molecular pathology and functional genomics of lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Exploration of the evidence of cancer stem cells in lung cancer
M. Arifin, K. Tanimoto, E. Hiyama, M. Nishiyama, K. Hiyama (Hiroshima, Saitama, Japan)
Source:
Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer
Session:
Hot topics in molecular pathology and functional genomics of lung cancer
Session type:
Oral Presentation
Number:
3257
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Arifin, K. Tanimoto, E. Hiyama, M. Nishiyama, K. Hiyama (Hiroshima, Saitama, Japan). Exploration of the evidence of cancer stem cells in lung cancer. Eur Respir J 2009; 34: Suppl. 53, 3257
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Related content which might interest you:
Lung stem cells and lung cancer
Source: ERS Lung Science Conference 2017
Year: 2017
Intersections of lung progenitor cells, lung disease and lung cancer
Source: Eur Respir Rev, 26 (144) 170054; 10.1183/16000617.0054-2017
Year: 2017
Stem cells and lung cancer
Source: Eur Respir Monogr 2021; 91: 340-352
Year: 2021
Epigenetics and lung cancer
Source: Annual Congress 2006 - Epigenetics and respiratory disease
Year: 2006
Clinical implication of stem cell markers in N2 positive non-small cell lung cancer
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012
Ghrelin does not influence cancer progression in a lung cancer cell line and mice with lung adenocarcinoma
Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Year: 2018
The role of stem cells in cancer
Source: Research Seminar 2015
Year: 2015
Venothromboembolism in lung cancer
Source: Eur Respir J 2007; 30: Suppl. 51, 601s
Year: 2007
Aerosoltherapy in lung cancer
Source: Annual Congress 2008 - Therapy in thoracic oncology
Year: 2008
Circulating CD133(+) stem cells in lung cancer patients
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011
New treatment options for nonsmall cell lung cancer and small cell lung cancer
Source: Annual Congress 2006 - PG12 - Small cell lung cancer management
Year: 2006
A non-small cell lung cancer modelling by endogenous κ-ras manipulation
Source: Annual Congress 2005 - Pathophysiology of lung cancer progression: impact in diagnosis and early detection
Year: 2005
Clinical characterization of non-small cell lung cancer tumors showing neuroendocrine differentiation
Source: Eur Respir J 2002; 20: Suppl. 38, 270s
Year: 2002
Modulation of tumor-microenvironmental factors and cancer growth in co-cultures of fresh human lung tissue and patient-derived cancer cells
Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Year: 2018
Lung cancer
Source: Respipedia Article
Year: 2018
Second primary lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 73s
Year: 2004
Management of extensive disease-small cell lung cancer
Source: Eur Respir Mon; 2009: 44: 310–317
Year: 2009
New chemotherapeutic agents
Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=259
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept